Mimetas said today that it collaborated with Roche (OTC:RHHBY) to develop an organ-on-a-chip system that is designed to evaluate intestinal permeability in 3D gut tubules following exposure to drug compounds.
The results of the collaboration were published in Nature Communications.
Get the full story at our sister site, Drug Delivery Business News.
The post Roche, Mimetas develop “gut-on-a-chip” tech for drug-testing appeared first on MassDevice.
from MassDevice http://ift.tt/2wPKdcJ
Cap comentari:
Publica un comentari a l'entrada